YAP1 and neoplasm: As regards immunotherapy, YAP/TAZ-TEAD can directly target the PD-L1 gene and enhance its promoter to increase expression while inhibiting activity of CD8+ T lymphocyte, thus enabling immune escape of tumor cells (12, 41) (Table 1).